Daniel Loeb

Daniel Loeb

Last Update: 05-13-2016

Number of Stocks: 37
Number of New Stocks: 13

Total Value: $10,857 Mil
Q/Q Turnover: 25%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

Daniel Loeb Watch

  • Daniel Loeb Beats Market But Stocks Down

    Third Point investor Daniel Loeb (Trades, Portfolio) posted a higher return than the S&P 500 index in June, saved from negative performance by gains in his bond portfolio.


    Loeb’s Third Point Offshore Fund returned 0.8% for the month, compared to 0.3% for the index. It was the third month this year he outperformed the market, but the fund is still falling short for the year through June 30, gaining 2.1% with the index up 3.8%. Loeb’s returns have been on an upswing for the past four months, with credit boosting returns since March while long positions struggled.

      


  • Richard Perry Trims Time Warner, AIG

    Richard Perry (Trades, Portfolio) co-founded private investment management firm Perry Capital LLC in 1988, which manages about $14 billion as of August 2008. The following are his largest deals during the first quarter:


    The investor exited his stake in Williams Companies Inc. (WMB) with an impact of -10.02% on the portfolio.

      


  • Daniel Loeb Invests in Intercontinental Exchange

    During the first quarter Daniel Loeb (Trades, Portfolio) purchased 225,000 shares of Intercontinental Exchange Inc. (NYSE:ICE) at an average price of $243.36 per share.


    IntercontinentalExchange Group was originally founded in the year 2000 but changed its name to Intercontinental Exchange on June 2, 2014. The company operates regulated global marketplaces for trading and clearing an array of securities and derivatives contracts across major asset classes including interest rates, equities, equity derivatives, credit derivatives, and bonds. The company exchanges include futures in the U.S., U.K., continental Europe, Canada and Singapore and cash equities exchange and equity options exchanges in the U.S.

      


  • Is Seasonal Investing the Best Way to Approach the Market?

    What happens when the markets stop making sense? How do you even begin to analyze which stocks to invest in?


    Over the last two years, markets have defied conventional theories, rallied even when the global economies appeared to be struggling and in the process managed to sway several investors into believing that everything was on a roll.

      


  • Daniel Loeb Comments on Danaher

    Danaher (DHR) is a diversified multi-industrial company with an increasing exposure to life science and healthcare-oriented businesses. Operating across five different business segments and built up through over 400 acquisitions over the company’s history, the cornerstone for Danaher’s successful integration and value creation strategy has been the


    Danaher Business System (DBS). Adapted from Japanese principles of kaizen, DBS has evolved into a set of processes and corporate culture revolving around continuous improvement, helping to drive organic growth and annual margin improvement across Danaher’s portfolio.

      


  • Daniel Loeb Comments on Chubb Ltd.

    Chubb Ltd. (CB) is the product of ACE Limited’s acquisition of The Chubb Corporation which closed in January. The deal combined two world-class operators that have consistently put up ~90% combined ratios – almost 900bps better than North American peers – and have compounded book value at 10%+ the past decade, more than double that of peers. The new Chubb is the largest public pure-play P&C company by underwriting income. It also has a number of factors we look for in a pro forma situation: an A+ CEO in Evan Greenberg; complementary fit across products, distribution, and geography; and a plan that is less focused on short-term cost savings than long-term strategic opportunities for growth, which are abundant.


    Chubb’s scale and focus on growth could not come at a better time as certain competitors scale back operations to satisfy shareholder demands. We are willing to forego short-term cost cuts or buybacks to own a franchise that is a long-term winner with the premier franchise in US high-net-worth insurance, #1 share in global professional lines, and an enviable global platform with leading A&H and personal lines in Asia and Latin America. We view Chubb as a high-quality compounder in the financials space, with double-digit earnings growth potential over the next few years. Critically, this earnings power is far less sensitive to rates and credit quality than fundamental execution.

      


  • Daniel Loeb Comments on Charter Communications

    Charter Communications (CHTR) is a domestic provider of voice, video, and high-speed data. In May 2015, Charter announced the acquisition of Time Warner Cable. This is a transformational deal that quadruples the company’s scale while driving substantial operating efficiencies. Importantly, the pro forma company will be led by Charter’s current CEO, Tom Rutledge, who we view as one of the best operators in the industry.


    New Charter is well positioned to capture market share from satellite and telco competitors given its advantaged high-speed data product. In addition, Mr. Rutledge’s track record of boosting video penetration, driving down service costs, and executing large network transformations at legacy Charter makes us optimistic about his leadership of the new entity.

      


  • Daniel Loeb Comments on Molson Coors Brewing Company

    TAP (NYSE:TAP), on the other hand, stands to benefit greatly from acquiring divested assets. The company is picking up the remaining 58% share of the MillerCoors US joint venture that it does not already own, the perpetual rights to import legacy SAB global brands such as Peroni in the US, and the global rights to the Miller brand. The transaction is highly accretive for TAP given the sheer size of the acquired assets. It also gives the company full control over its most important market, something that ought to improve operational effectiveness and increase the long-term strategic value of the company to a potential acquirer as the global beer industry continues to consolidate. As is the case with BUD, we believe TAP will compound nicely over the next several years as the market more fully appreciates the earnings power and strategic optionality of the pro forma company.

    From Daniel Loeb (Trades, Portfolio)'s first quarter 2016 shareholder letter.   


  • Daniel Loeb Comments on Anheuser Busch InBev

    The long awaited acquisition of SAB Miller (SAB) by Anheuser Busch InBev (BUD) announced late last year created two interesting pro forma situations. The deal, expected to close in the second half of 2016, will combine the two largest global brewers and create an unrivaled player with strong pricing power in an increasingly consolidated global industry. It will also transform Molson Coors (TAP) into a stronger regional competitor following the acquisition of certain SAB assets that must be sold for anti-trust reasons.


    Starting with BUD, we think the stock ought to grow nicely over the next several years as the true earnings power of the new company is revealed. Part of the gains will come from improving the underlying profitability of SAB, as operational control of its assets is transferred to BUD’s highly regarded management team led by CEO Carlos Brito. Another part will come from the capture of deal-related cost and revenue synergies, as duplication is eliminated and BUD’s global brands like Budweiser, Corona, and Stella are rolled out to legacy SAB markets in Africa and Latin America. Finally, the rest should come from financial engineering as BUD’s under-levered balance sheet is monetized to help finance the transaction. We also think the new company will likely command a higher valuation as SAB’s emerging market exposure will be accretive to top line growth over time.

      


  • Daniel Loeb Comments on Dow Chemical

    We are encouraged by the latest developments in our investment in Dow (DOW) which announced a merger with DuPont in December. In February, the company revealed that long-time CEO Andrew Liveris will be stepping aside not long after the merger’s completion. DuPont’s CEO, Ed Breen, is a proven operator and capital allocator. Breen made his mark by streamlining Tyco, a long-time industrial conglomerate, splitting the company into focused units and thus created enormous shareholder value. He brings an unbiased perspective and is not afraid to challenge the status quo, two qualities that will be essential in leading Dow/DuPont given the histories of both of these conglomerates.


    We continue to believe there is potential for operational improvement at Dow that would be incremental to the $3 billion announced synergy target; in aggregate, approximately $5 billion of earnings improvement could be unlocked. The merger structure preserves both companies’ strong balance sheets which, combined with fading Sadara and Gulf Coast CapEx, should allow for meaningful capital return while maintaining a strong investment grade balance sheet. Taking all of these factors into account, we believe the pro forma entity is capable of generating $5.50 – 6.00 of EPS in 2018. Given that these earnings will consist of contributions from several focused spinoffs, we also believe that multiple expansion is likely.

      


  • Quality Guru Stocks Include Amgen, Comcast

    According to GuruFocus’ All-in-One Screener, the following stocks have a high business predictability rating and at least five gurus are shareholders in the companies.


    WestRock Co. (WRK)

      


  • Why Dan Loeb Is Adding to His Green Brick Position

    Green Brick Partners (NASDAQ:GRBK) is a land development company with a bank of land in favorable parts of the Dallas and Atlanta areas. In addition it owns controlling interests (of exactly 50%) in four homebuilding companies.


    The company was set up and customized around 2008 by guru David Einhorn (Trades, Portfolio), of Greenlight Capital and Jim Brickman, who was going to lead it. Brickman has 35 years of experience in the business. Einhorn owns ~50% of the equity and Brickman around 10% through various names. They called it Green Brick. Get it?

      


  • Daniel Loeb Adds to Stake in Green Brick Partners

    Daniel Loeb (TradesPortfolio) added 99,943 shares to his stake in Green Brick Partners Inc. (NASDAQ:GRBK) on April 8.


    Green Brick Partners (formerly known as BioFuel Energy Corp.) was incorporated as a Delaware corporation on April 11, 2006. The company began its original operations with the intention of solely investing in BioFuel Energy LLC, a limited liability company organized on Jan. 25, 2006. The company's goal was to build and operate ethanol production facilities in the Midwestern U.S.

      


  • Art Collecter Daniel Loeb Adds Sothebys to Portfolio

    Guru Daniel Loeb (Trades, Portfolio) is a California native who grew up in Santa Monica. Loeb received his bachelor's at Columbia and spent the next 11 years working for various firms including Warburg Pincus, a private equity firm. He then landed a job working as director of corporate development at Island Records, a record label where he focused on securing debt financing.


    After his time at Island Records, Loeb seized an opportunity to work as a risk arbitrage analyst at Lafer Equity Investors, and then from 1991 to 1994 he worked as senior vice president in the distressed debt department at Jefferies LLC. Loeb increased his knowledge and experience about bankruptcy analysis, trading bank loans and selling distressed securities. In 1995, Loeb founded Third Point Management LLC, which has grown to a total value of about $9.86 billion.

      


  • Dan Loeb's Third Point Portfolio Highly Concentrated

    Daniel Loeb´s Third Point disclosed an equity portfolio valued at some $9.86 billion at the end of the fourth quarter of 2015. The equity portfolio is mainly invested in Health Care (53%), Materials (17%) and Consumer Discretionary (11%) stocks.


    Among the 10 largest holdings from Loeb’s equity portfolio (which compose 82.43% of the total portfolio value) at the end of the fourth quarter, the three top positions are Baxter International Inc. (NYSE:BAX), Allergan PLC (NYSE:AGN) and Amgen Inc. (NASDAQ:AMGN).

      


  • 3 Attractive Asset Management Firms


    Charlie Bobrinskoy recently appeared on CNBC and shared his insights regarding several of the value investing firm’s long positions.

      


  • Third Point's Quarterly Letter

    Markets are off to a tumultuous start for the year, as many indices show1: the S&P (- 10.3%); the NASDAQ (-14.7%); the DAX (-18.5%); the NIKKEI (-17.4%); and the Shanghai Composite index (-21.9%). Last year’s darlings like Amazon (NASDAQ:AMZN) (-25.5%) and Netflix (NASDAQ:NFLX) (-24.5%) have fallen meaningfully in 2016, but hardest hit have been some companies seen as “value” stocks like Williams (NYSE:WMB) (-48.3%), Bank of America (NYSE:BAC) (-33.7%), and Morgan Stanley (NYSE:MS) (- 31.4%). We believe the indices’ drastic declines actually fail to capture the true carnage revealed when you take a closer look at the breadth of S&P companies experiencing massive losses. In some cases, these losses may represent permanent value destruction. The 2015 market we dubbed a “Haunted House” feels about as scary as the Disney (NYSE:DIS) kids’ ride “It’s a Small World” when compared to 2016.


    Last August, we recognized that a global tidal shift in monetary policy and a reversal in central bank policy would likely cause fund flows out of many asset classes. We reduced our exposure to companies that were economically sensitive or tied to China or to commodity pricing while significantly increasing our short exposure. For the remainder of 2015, we generated profits on the short side but were hurt by our decision to seek safe haven in health care names and other companies we believed would remain sheltered from the new world order. We succeeded in avoiding calamitous losses in the portfolio and preserved our clients’ capital in 2015.

      


  • Daniel Loeb Buys Axalta, Morgan Stanley, Chubb

    Daniel Loeb (Trades, Portfolio) made three new additions to his portfolio in the fourth quarter: Chubb Ltd. (NYSE:CB), Morgan Stanley (NYSE:MS) and Axalta Coating System Ltd. (NYSE:AXTA).


    Loeb manages the event-driven, value-investing hedge fund Third Point, which has $17.5 billion in assets. Third Point’s main Offshore Fund was down 3.4% in January, versus a 5% loss for the S&P 500. He has achieved a historical annualized return of 15.9%, compared to 7% for the index.

      


  • Dan Loeb's Third Point Re a Good Bet in Declining Markets

    As we wrote in our previous article on Third Point Re (NYSE:TPRE), Daniel Loeb's investment record is beyond reproach. Since 1995, he has generated one of the best long-term investment track records in history, averaging 19.5% annual returns for over 20 years.


    As you can see below, however, the past year or two has been tough for value investors. In 2014 and parts of 2015, his fund lagged the markets. Third Point Re (his reinsurance company that invests in his hedge fund's strategy) is down almost 40% from its highs in 2014. Even if you don't believe that markets will continue to rise, buying into his investment strategy through shares of Third Point Re may be a great idea.

      


  • Facebook, McDonald's Among Guru Stocks Outperforming S&P 500

    The following are some of the stocks that outperformed the S&P 500 Index over the last 12 months and have been bought by gurus during the last quarter.


    Facebook Inc. (FB) with a market cap of $327.41 billion, during the last 12 months has outperformed the S&P 500 Index by 55.7% and currently, 14 gurus are holding the stock that has returned 14% year-to-date and 205% during the last five years. It is now trading with a P/E ratio of 116.45 but according to the DCF calculator, it looks overpriced by 1,000%.

      


  • Dan Loeb's Third Point Re a Tremendous Value

    It’s not often that you can buy into a legendary value investor hedge fund at a discount. Third Point Re (NYSE:TPRE) might be the exception.


    Ever since Warren Buffett’s Berkshire Hathaway (NYSE:BRK.A)(NYSE:BRK.B) found long-term success, hedge fund managers have scrambled to set up their own insurance companies. In this structure, the insurance entity focuses on underwriting policies, while the premiums are managed by the hedge fund manager.

      


  • Stocks Trading With Low PS Ratio, Wide Margin of Safety

    According to GuruFocus' All-In-One Screener, the following are stocks of companies with a market cap above $5 billion that are trading with a very low P/S ratio.


    Dow Chemical Co. (DOW) is trading at about $41 with a P/S ratio of 0.98, a trailing 12-month P/E multiple of 10.69 and an estimated forward P/E multiple of 10.49. The company has a market cap of $47.87 billion and over the last 10 years, the stock has dropped by 3%. During the last 52 weeks, the price has been as high as $57.10 and as low as $35.11.

      


  • Jana Partners Dumping Half of Hertz Holdings

    Guru Jana Partners (Trades, Portfolio) seriously started racking up its exposure to Hertz (NYSE:HTZ) at the end of 2014.


    Ultimately Jana Partners (Trades, Portfolio) owned about 41 million shares of the car rental business that owns the Hertz, Dollar, Thrifty and Firefly brands. Its network of rentals spans the globe with storefronts across North America, Europe, Latin and South America, Asia, Australia, Africa, the Middle East and New Zealand. Back at the end of August the company started decreasing its exposure, but now it has seriously cut back on its stake, selling 44.70% at once.

      


  • Richard Pzena's Undervalued Stocks Trading With Low P/Es

    Richard Pzena is founder and co-chief investment officer of Pzena Investment Management LLC with more than $24 billion under management. Pzena started the firm in 1995. He earned a B.S. summa cum laude and an M.B.A. from the Wharton School of the University of Pennsylvania in 1979 and 1980.


    The following are the stocks of his portfolio that are undervalued and are trading with a low P/E ratio.

      


  • Dan Loeb's Largest 3rd Quarter Investment Was Kraft Heinz Co.

    Billionaire Daniel Loeb (Trades, Portfolio) founded the hedge fund Third Point in 1995, which manages about $17 billion. Loeb is an activist investor and Third Point follows an event-driven, value-oriented investment style.

    During the third quarter, Loeb added four new holdings to the portfolio, while closing out 17 other positions.  


  • Why Daniel Loeb Is Putting 15% of His Portfolio Into Baxter

    Guru Dan Loeb leads Third Point LLC and recently built up a large stake in Baxter International (NYSE:BAX), which now makes up about 15% of his portfolio. Since that time he has requested and been granted two board seats and helped to install the new CEO. Loeb has not taken the aggressive approach (given the soft tone of his letter to the company) he is known for that usually tends to grab the attention of the financial media. It’s a bit of a stretch to say this one is flying under the radar, but it definitely has not attracted as much attention as his Sotheby’s (BID) or Sony campaigns.


    There are a few clear reasons for his soft approach. Baxter was already in need of a new CEO; Loeb just wanted to get involved in that search and he brings a lot of expertise to the table. He is, after all, somewhat of a specialist in kicking people out, which inevitably requires you put in someone new who is actually an improvement. His usual venemous rhetoric was not required to get a shareholder value centric CEO Joe Almeida of Covidien (COV), installed. Almeida really has a pretty good track record for value creation:

      


  • David Einhorn and Dan Loeb Love This Company

    With a market cap under $400 million, a complex business structure and a winding operating past, it's little wonder that most investors haven't heard of Green Brick Partners Inc. (GBRK).


    Green Brick Partners is a residential real estate company that develops residential communities and holds interests in several different homebuilders. According to its website, it controls approximately 4,800 prime home sites, originates approximately 1,000 secured first lien loans each year and owns a controlling interest in four homebuilding companies in Dallas as well as the fifth-largest homebuilder in Atlanta.

      


  • Daniel Loeb Comments on Seven & i Holdings

    Seven & i Holdings


    During the third quarter, we continued to add to our investment in Japan's Seven & i Holdings (TSE:3382) (the parent company for the 7-Eleven franchise) at attractive valuations. The company has a $40 billion market cap and derives more than 100% of its cash flow from the operation of a 90%-franchised convenience store network in Japan, the U.S. and Southeast Asia.

      


  • Daniel Loeb Comments on Baxter International Inc.

    Baxter International Inc.


    During position: the third quarter, we disclosed a 9.9% stake in Baxter International Inc. making us the company’s largest shareholder. Baxter provides critical, life-saving materials to patients and physicians in over 100 countries with an emphasis on renal care and medical products.

      


  • Daniel Loeb Increases Bet on Japan as Existing Holdings Decline

    Daniel Loeb (Trades, Portfolio)’s conviction on Japan he made public several years ago has not abated this year as he made clear by taking several stakes in the country in recent months. As he discloses a new activist long position in the country, Seven & i, several of his positions have yet to post gains.


    The investor’s interest in Japan lies primarily in Prime Minister Shinzo Abe’s economic reforms. Loeb believed they could open Japanese companies to American-style investor influence for the first time, laying bare corporate weaknesses and creating a hotbed for activist investors such as him. Loeb, founder of the hedge fund Third Point, declined to comment, but his staff pointed to a Wall Street Journal piece from several years ago in which he outlined his views on the country.

      


  • Third Point's Third Quarter Letter

    Daniel Loeb's Third Point has released their third quarter letter to shareholders. In the letter Loeb discusses macroeconomics and the Federal Reserve's fiscal policy. Loeb also discusses his firm's 9.9% stake in Baxter Intenational Inc. (NYSE:BAX).


    Third Point Letter:

      


  • Undervalued Stocks With Low P/E Among Meridian Funds' Holdings

    Richard Aster is the founder of Aster Investment Management Company and he manages both Meridian Value Fund and Meridian Growth Fund. According to GuruFocus the hedge funds have a total value of $2,681 million and the following are the top 5 of the 149 stocks of the portfolio that are trading with a wide margin of safety according to the DCF calculator and with a a low P/E ratio.


    Baxter International Inc.

      


  • Loeb, Ackman's Portfolios Post Losses for Year as Top Bets Fall

    During a volatile market during the third quarter, several prominent hedge funds saw their returns decline.


    Pershing Square, Bill Ackman (Trades, Portfolio)’s fund, fell 12.5% in September, bringing its total third quarter decline to 15.3%. This compares to the HFRX Equity Hedge Index low of 2.08% for September. It also declined 12.6% for the first three quarters of the year, compared to the index decline of 3.13%. The first two weeks of the fourth quarter fared better, up 3.6%, but the total year-to-date decline still languished at 9.4%.

      


  • Is Baxalta a Good Spin-Off Opportunity?

    A number of well-known guru investors hold Baxalta (NYSE:BXLT), the biopharmaceutical pure-play spin-off from medtech parent Baxter. These include Tweedy Browne (Trades, Portfolio), Daniel Loeb (Trades, Portfolio) and Richard Pzena (Trades, Portfolio). Is it a good buy for investors at a current price of $33?


    In this stock note, I consider historical performance, upside, risks, valuation and a suggested buy price.

      


  • McKesson Officer Sells 101,835 Shares of Company

    McKesson Corp. (MCK) CEO, President and Chairman John Hammergren (Insider Trades) sold 101,835 shares of the company on Oct. 12. The average price per share was $190.51. McKesson is a healthcare service and information technology company dedicated to making the business of healthcare run well. The company has a market cap of $44.11 billion and a P/S ratio of 0.24.


    The number and volume of insider sells ranged from 24 to 45, and 724,166 shares to 1,718,598 shares from 2012 to 2015. Despite the nearly 100% increase of month end price in those years, the number and volume of insider sells did not increase accordingly. On average, each insider buy during this period of time amounted to about 30,000 shares. Hammergren sold 2,750,000 shares of the company in 21 transactions since August 2010. His earliest transaction increased about twofold since then. There were no insider buys during this time. 1444860871892.png 1444860878438.png For more information about insider transactions of the company, click here.

      


  • Activist Hedge Fund Manager Dan Loeb Increases Position in Leading Biotech Company

    Daniel Loeb’s Third Point LLC disclosed Wednesday that he increased his stake in Baxter International Inc. (NYSE:BAX), a medical equipment and supplies company, by purchasing an additional 11.97 million shares at an average price of $32.69 per share.


    After the transaction, the trader held 53.85 million shares. The stock has dropped 15.48% over the past year and traded around $32.85 per share by Wednesday closing, which was near its May price.

      


  • Apigee CEO Buys 5,000 Shares of Company

    Chetan Kapoor (Insider Trades), CEO and president of Apigee Corp. (APIC), bought 5,000 shares on Tuesday. The average price per share was $10.03, for a total transaction of $50,150. Apigee provides an intelligent API platform for digital business. The company’s market cap is $309.75 million, and P/S ratio is 4.39.


    Seven APIC insiders bought 320,844 shares in seven total transactions since April. The earliest transaction decreased about 40% in price since the purchase. Kapoor’s buy on Tuesday contributed to only 1.6% of the sum of insider shares bought since April. Stacey Giamalis (Insider Trades), APIC chief counsel, bought 344 shares in the company today. The average price per share was $10.48. Another company insider, Anant Jhingran (Insider Trades), APIC chief technology officer, bought 3,800 shares of the company on Friday. The average price per share was $10.73. 1443644300598.png 1443644310152.png

      


  • Charles Brandes' Most Weighted Trades in Q2 2015

    Charles Brandes is the chairman of Brandes Investment Partners. He manages a portfolio composed of 195 stocks with a total value of $7.80 billion and the following are his most weighted trades in the last quarter :


    He reduced his stake in Masco Corp. (MAS) by 34.23% with an impact of 0.67% on his portfolio.

      


  • Activist Hedge Fund Manager Dan Loeb Decreases Position in Leading Biotech Company

    Daniel Loeb's Third Point disclosed an equity portfolio valued at some $10.68 billion at the end of the second quarter. Among the 10 largest holdings from Loeb’s equity portfolio (which comprises 56.81% of the total portfolio value), the three top positions are: Amgen Inc. (NASDAQ:AMGN), Dow Chemical Company (NYSE:DOW) and Allergan PLC (NYSE:AGN).


    Amgen is a $110.26 billion market cap company that has major treatments for anemia, neutropenia, rheumatoid and psoriatic arthritis, psoriasis, cancer and osteoporosis.

      


  • Undervalued Stocks Among Mario Gabelli's Recent Buys

    Mario Gabelli (Trades, Portfolio) is the founder, chairman and CEO of Gabelli Asset Management Company Investors (GAMCO Investors) and at the end of the last quarter, his portfolio was composed of 834 stocks with a total value of $18.5 billion.


    According to GuruFocus' All-In-One screener, the following are the companies he recently bought with a wide margin of safety.

      


  • Dan Loeb Buys T-Mobile During Second Quarter

    Activist investor Daniel Loeb (Trades, Portfolio) founded hedge fund Third Point LLC in 1995, which today manages about $17 billion in assets. The firm’s strategy involves identifying situations with a catalyst that will unlock value.


    Loeb is well-known for penning scathing public letters to CEOs and companies he disapproves of, prompting Vanity Fair to publish excerpts of his top 10 letters in a 2013 feature.

      


  • Stocks Gurus Are Buying - Part I

    According to GuruFocus' All-in-One screener, the following stocks were six of the most popular among the gurus during the past three months. 



      


  • Dan Loeb Sees Opportunity in Latest Target Baxter International

    Serial 13D-filer Daniel Loeb (Trades, Portfolio) defended shareholder activism in his July letter and moved on to his next target, Baxter International (NYSE:BAX), on Tuesday.


    The company of which Loeb’s Third Point purchased 37,925,000 shares – a 7% stake costing $1.52 billion – has already shaken itself up somewhat. It spun off its biopharmaceutical business, Baxalta (NYSE:BXLT), on July 1, and is focusing on home, hospital and in-center therapies. Its board has also formed a working group to search for a new CEO, as its current chief executive, Bob Parkinson, 64, has spent 11 years at the company.

      


  • Daniel Loeb's Third Point Second Quarter Investor Letter

    Review and Outlook


    On June 1st, Third Point completed its 20th year of investing. Since we like numbers, we will share some statistics about our performance. Over the past two decades, we have generated annualized returns of 20.5%, cumulative returns of over 4000%, and gross trading profits of over $12 billion for our investors. Over the same period, the S&P 500 had annualized returns of 9.1% and cumulative returns of 475%. Our average monthly return has been 1.6% and our average quarterly return has been 5.0%, each roughly double the S&P’s return over the same periods. Finally, we have done this with a correlation to the S&P of only 0.4.1

      


  • A Look at June's Hedge Funds Returns

    The $3 trillion hedge-fund industry tumbled probably due to two important effects. On the one hand, Greece’s debt situation and on the other hand the recent performance of the Chinese stocks. In simple words, June was a bad month for stocks and for hedge funds, too.


    The Hedge Fund Research HFRI Weighted Composite Index dropped 1.3% and that percentage is its worst monthly loss since June 2013. In June, the HFRI Macro Index fell 2.4% and ended with the year to date gains of that index. In line with this, the SPDR S&P 500 ETF Trust (SPY) returned a negative 2.5% in June, but the total returns for the index for the year through Jul 14 was 2.3%.

      


  • Martin Whitman Recent Buy: Masco Corp

    Martin Whitman (Trades, Portfolio) is founder and portfolio manager of the Third Avenue Value Fund. Whitman is a 1949 graduate of Syracuse University, which recently renamed its School of Management after Whitman, after a large gift from him in June 2003. He is an adjunct faculty member at Yale School of Management.


    During 2015 Q2 the investor bought a big stake of Masco Corp (MAS) with an impact of 2.13% on his portfolio. He bought 1,479,930 shares that is the 0.43% of outstanding shares of the company. Since that buy, the price of the stock didn’t face any change.

      


  • Daniel Loeb Parts With Stake in Alibaba

    Hedge fund manager Daniel Loeb (Trades, Portfolio), the founder and chief executive of Third Point LLC, a New York-based hedge fund with a $14 billion portfolio, is known for his public letters that have been critical of CEOs and other investment managers. His approach to investing is event-driven and value-oriented.


    While he has said he is only interested in making money for his investors, his personal portfolio activity in the first quarter shows he is also interested in making money for himself as well.

      


  • FedEx Is a Long-Term Buy

    In this article let's take a look at FedEx Corporation (NYSE:FDX), the leader in global express delivery services, which provides guaranteed domestic and international air express, residential and business ground package delivery, heavy freight and logistics services.


    Although revenue increased, when compared to the same quarter one year before, it was below the forecast. Also, the company reported weaker earnings than expected from analyst estimates. Earnings of $2.66 per share missed estimates of $2.68. Among the reasons we found were the currency translation and the falling fuel surcharges. After the earnings were released, the stock price plummeted by 3% to $176. In what we consider a five-year period, EPS has grown by 14% annually.

      


  • Dan Loeb increases his stake in Roper Industries

    Daniel Loeb (Trades, Portfolio) is a well-known activist investor. He founded Third Point LLC in 1995 and leads the firm’s research activities, portfolio, and risk management. Third Point’s total assets are more than $2.2 billion, and Loeb’s personal net worth is $2.3 billion.


    Last quarter, Loeb bought 300,000 shares of Roper Industries (NYSE:ROP). As of March 31, 2015, he was holding 1.6 million shares of the company. The following chart shows Dan Loeb's holding history in the company.

      


  • Daniel Loeb's New Positions for 1QFY15

    Daniel Loeb (Trades, Portfolio) of Third Point, LLC recently added nine new positions to his portfolio during 1QFY15. He currently owns 40 stocks and his portfolio has a total value around $10.76 billion and a 14% quarter over quarter turnover.


    27.2% of Loeb's portfolio is made up of stocks in the healthcare sector. Next is the consumer cyclical sector, which consists of 14.3% of his portfolio and basic materials, which is 12.3% of the portfolio.

      


  • Daniel Loeb's Third Point First Quarter 2015 Commentary

    First Quarter 2015 Investor Letter

    I founded Third Point on June 1, 1995 with $3.4 million in capital from five intrepid investors – all close friends and family – and my own nest egg. My goals were to compound at 20% and grow to $20 million in assets. Nearly twenty years later, we have been able to meet our initial return goals (despite over-shooting our asset base target) as a result of remarkable individuals who have come together to form our team. The keys to our success have been remaining entrepreneurial, creative, committed to organizational and individual improvement, rigorous about our process, and singularly focused on achieving superior risk-adjusted returns for our investors.

      


  • Manning & Napier Jump Into Alibaba

    Manning & Napier Advisors Inc. was founded in 1970 and as of December 31, 2014 the company was managing $47.8 billion in assets. The portfolio is composed of 369 stocks and has a Q/Q Turnover of 29%.


    During 1Q2015, the company traded many stocks, but the main addition was to Alibaba Group Holding Ltd. (BABA), with an increase of 11489.89%, which resulted in a weight of 0.65% to the portfolio. BABA is part of the Retail – Apparel & Speciality sector.

      


  • Should You Buy EBay Post Recent Analyst Upgrade?

    Recently, Susquehanna analyst James Friedman upgraded his rating on eBay (NASDAQ:EBAY) to buy from neutral. He also raised his stock price target to $75, which implies significant upside from the current levels. Friedman is bullish about Paypal's business prospects once it demerges from eBay.


    In addition to positive sell side commentary eBay has also seen a lot of interest from fund managers of late. Last quarter, Seth Klarman (Trades, Portfolio), Daniel Loeb (Trades, Portfolio), Larry Robbins (Trades, Portfolio), Leon Cooperman (Trades, Portfolio), NWQ Managers (Trades, Portfolio), Jana Partners (Trades, Portfolio), PRIMECAP Management (Trades, Portfolio), Murray Stahl (Trades, Portfolio), RS Investment Management (Trades, Portfolio) and Louis Moore Bacon (Trades, Portfolio) increased their stake in the company.

      


  • A look at Daniel Loeb's investment in Delta Airlines

    Airline companies are notorious for burning cash. Serial Entrepreneur Richard Branson once said, "If you want to be a millionaire, start with a billion dollars and launch a new airline". With falling oil prices, things appear to have been turning around for the sector. Most of the airline stocks have seen good run up over the last few months backed by improved profitability. Many big name investors are now looking for quality names in the sector.


    Last quarter, Billionaire Hedge fund manager Daniel Loeb (Trades, Portfolio) initiated a position in Delta Airlines (DAL) by buying 3.85 million shares. This is the first time he has taken a stake in the company.

      


  • Analyzing Daniel Loeb's Top Buys: Masco Corporation

    Daniel Loeb (Trades, Portfolio) is well known activist investor. He founded Third Point LLC in 1995 and leads the firm’s research activities, portfolio, and risk management. Third Point’s total assets are more than $2.2 billion, and Loeb’s personal net worth is $2.3 billion.


    Last quarter, Loeb bought 1.9 mn shares of Masco Corporation (NYSE:MAS). As of December 31, 2014, he was holding 10 mn shares of the company. The following chart shows Dan Loeb's holding history in the company.

      


  • Daniel Loeb's Comments on Fanuc

    During the fourth quarter we invested in Fanuc ( FANUY), the leading factory automation and robotics company in the world with a market capitalization of $33 billion and an enterprise value of $25 billion. Based in Japan and spun out of Fujitsu in the 1970’s, Fanuc is a unique company with a long history of being the best and fastest to market in everything it does. Its visionary founder describes the Company’s mission as “walking the narrow path,” which refers to its relentless focus on producing only a limited number of products that are technically superior with the lowest possible cost structure. This targeted innovation combined with a strong emphasis on reliability and service has made virtually all of Fanuc’s products blockbusters. While serving completely different, cyclical markets, Fanuc reminds us of Apple in its product approach.


    In its core Factory Automation division, Fanuc has capitalized on structural growth in automation by creating a huge moat in Computerized Numerical Control (“CNC”) systems and servo motors. It has become the global standard for machine tool control software and motors with a worldwide market share of 60%. The Company has built a global service/aftermarket support organization that is unrivaled by competitors in a business where switching costs are high. The division’s revenue correlates closely to Japanese machine tool orders, which are on the rise for multiple reasons including strong demand from the US and a depreciating yen. Additionally, Chinese factory automation is a substantial growth opportunity as rising wages, low productivity, and quality issues force companies in the region to automate. To get a sense of the opportunity: China’s CNC penetration rate of 30% today equals Japan’s levels 40 years ago. Fanuc is expanding CNC capacity by 40% in the next twelve months to meet these higher demand levels. Fanuc’s Robots division has achieved a cumulative sales growth of 60% in the past two years, capitalizing on a robust opportunity set across all major economies. In China, automotive industry robot density is still at less than 15% of the levels seen in Japan, while general industry robot density is at less than 5% of Japan’s. In Japan, capital equipment replacement demand, some re-shoring of manufacturing and labor shortages are creating multiple drivers for robot demand. The resurgence in US manufacturing is also providing strong demand, as automotive and general industry customers are increasing orders for lifting, picking, welding, painting, and dispensing robots. Virtually every large manufacturing footprint expansion in North America – from Airbus to Ford to Tesla – is taking place with Fanuc’s robots. Fanuc’s internal development of low cost full artificial vision systems and collaborative robots makes it best positioned to drive adoption in industries that have traditionally been unable to automate. We think that these innovations will double the size of the Robots division in only a few years.

      


  • Investors Should Bet on this New York City-Based Insurer

    In this article, let's take a look at American International Group, Inc. (NYSE:AIG), a $75.29 billion market cap company that is a leading international insurance organization, which was rescued by various government entities in the financial crisis of 2008.


    Reverting 2008 crisis

      


  • Analyzing Daniel Loeb's Top Picks: eBay Inc (EBAY)

    Daniel Loeb (Trades, Portfolio) founded Third Point LLC in 1995 and leads the firm’s research activities, portfolio, and risk management. He is well known for his public letters in which he criticizes company CEOs or other investment managers. Third Point’s total assets are more than $2.2 billion, and Loeb’s personal net worth is $2.3 billion. Loeb and Third Point focus on activist investing, and follows an event-driven, value-oriented investment style. Loeb identifies situations in which a catalyst will unlock value. Last quarter Daniel Loeb (Trades, Portfolio) increased his holdings in eBay (NASDAQ:EBAY) by 122%. He currently holds 10 mn shares of the company. Here's a look at the company in detail.


    Company overview

      


  • Paul Tudor Jones Is Betting on the SPY, Should You?

    Over the past days hedge funds have been filing their form 13-F, which is a quarterly report of equity holdings by filed institutional investment managers with at least $100 million in equity assets under management, as required by the United States Securities and Exchange Commission (SEC).


    Hedge funds bought more than 15 million shares of the SPDR S&P 500 ETF Trust (SPY) worth $3.4 billion last quarter, according to data from 13-F filings compiled by Bloomberg. This ETF was the third-biggest aggregate increase in position by market value.

      


  • Why Hedge Fund Titans Like Delta Airlines (DAL)

    With crude prices declining, many investors are getting interested in airline stocks. Delta Airlines (NYSE:DAL), in particular, has seen many big name investors like Daniel Loeb (Trades, Portfolio), Julian Robertson (Trades, Portfolio), John Griffin (Trades, Portfolio), Mario Gabelli (Trades, Portfolio), Ken Heebner (Trades, Portfolio) and Whitney Tilson (Trades, Portfolio), buying its shares last quarter. The company's stock price has gained ~300% since the beginning of 2013, but its relative valuation is still one of the lowest among all S&P Industrial companies (see graph below).


    Delta's Relative Valuation versus S&P industrials

      


  • Daniel Loeb's Top 5 New Stock Buys of the Fourth Quarter

    Daniel Loeb (Trades, Portfolio), the CEO of hedge fund known for its periodic activist ventures Third Point, had significant portfolio turnover of 40% in the fourth quarter, with 12 new stocks added.


    In his fourth quarter shareholder letter, Loeb discussed his investing point of view for the current environment:

      


  • Daniel Loeb Comments on Fanuc Corp

    Equity Position: FANUC (TSE:6954, FANUY, FANUF)


    During the fourth quarter we invested in Fanuc (the “Company”), the leading factory automation and robotics company in the world with a market capitalization of $33 billion and an enterprise value of $25 billion. Based in Japan and spun out of Fujitsu in the 1970’s, Fanuc is a unique company with a long history of being the best and fastest to market in everything it does. Its visionary founder describes the Company’s mission as “walking the narrow path,” which refers to its relentless focus on producing only a limited number of products that are technically superior with the lowest possible cost structure. This targeted innovation combined with a strong emphasis on reliability and service has made virtually all of Fanuc’s products blockbusters. While serving completely different, cyclical markets, Fanuc reminds us of Apple in its product approach.

      


  • Daniel Loeb Comments on Amgen Inc

    Equity Position: Amgen (AMGN)


    Our biggest winner in 2014 was our equity position in the biotechnology company Amgen. In our last letter and at the Robin Hood Investment Conference, we highlighted Amgen as a hidden value situation where investor skepticism in three areas – R&D productivity, operating efficiency, and capital allocation – had obscured the company’s fundamental value.

      


  • Daniel Loeb’s Third Point Q4 2014 Investor Letter

    Review and Outlook


    Since the financial crisis, managing volatility and risk has proven to be almost as important as good stock-picking in generating investment returns. Last year emphasized this lesson, as investors struggled to cope with five drawdowns of greater than 3.9% in the SPX followed by swift rebounds within weeks. Third Point’s mediocre 2014 results, +5.7% in Offshore and +6.8% in Ultra, were due to a combination of poor trading during market volatility and bad judgment in exiting positions for reasons ranging from “overstaying our welcome” to impatience seeing our thesis through in choppy markets. Fortunately, there were bright spots in structured finance and enough winners in equity and government credit to help us eke out a mid-single digit return for our investors.

      


  • Why Soros, Burbank and Cohen Bought this Fairly Valued Stock

    In this article, let's take a look at Anheuser-Busch InBev SA/NV(NYSE:BUD), a $184.78 billion market cap company that is a brewing company and manages a portfolio of over 200 brands of beer.


    Good dividend yield

      


  • Different Hedge Fund Managers Bought and Added Molson Coors Brewing

    In this article, let's take a look at Molson Coors Brewing Company (NYSE:TAP), a $14.01 billion market cap company, which is the fifth largest brewer in the world, was formed in early 2005 via the combination of Adolph Coors Co. and Molson, Inc.


    Light Beer

      


  • The Broken-Leg Problem: Q&A with Abnormal Returns’ Tadas Viskanta about Deep Value

    Earlier this week I did a Q&A withAbnormal Returns’ Tadas Viskanta about Deep Value. Tadas sees more finance and investing content than anyone else, so it’s always interesting to see what he takes away from a topic:


      


  • Daniel Loeb Comments on Sony Corp

    In May of 2013, Third Point announced a significant stake in Sony (SNE) and suggested to the company’s CEO, Kazuo Hirai, that he should seriously consider spinning out 15‐20% of the company’s undervalued, American-based Entertainment business. At the time, we explained that partially listing the Entertainment segment would have three positive effects: 1) highlighting its profitability; 2) increasing investor transparency, thereby allowing the market to properly benchmark the company against its global media peers; and 3) incentivizing Entertainment’s management to run the company more efficiently by engaging in cost cutting and laying out clear earnings targets.


    While, regrettably, the Company rejected our partial spin-out suggestion, they made some changes that were consistent with our goals. In the Entertainment business in particular, Sony has cut costs, improved its dialogue with investors, and undertaken key management changes. In Electronics, Mr. Hirai’s team deserves credit for transitioning away from personal computers this year and improving television profitability in 2015. They have also improved investor transparency. Still, they have a long way to go and we continue to believe that more urgency will be necessary to definitively turn around the company’s fortunes.

      


  • Daniel Loeb Comments on Alibaba Group Holding Ltd

    In our Quarterly Letter two and a half years ago, we argued “the Case for Alibaba.” At the time, Alibaba (BABA) held a leading market position that it was just beginning to monetize (the company had less than $75 million in LTM earnings). Today, the Company has continued its exponential growth, demonstrated significant margin leverage, and is expected to earn over $5 billion this fiscal year. Our enthusiasm for the Alibaba story has underpinned multiple investments at Third Point and now that the company is public, we have established a significant direct investment in Alibaba shares.


    Third Point has met with management several times and is confident that Alibaba can generate long‐term value in its core markets and compete in new ones, making it a compelling potential multi‐year investment. The company has a substantial network effect that creates several large moats around its business, generating significant free cash flow for re‐investment and expansion as well as an unrivaled amount of data on Chinese consumers. We see continued end market growth in Chinese consumer spending and e‐ commerce (as well as global e‐commerce) and continue to believe that Alibaba has considerable additional monetization potential.

      


  • Daniel Loeb Comments on eBay

    We established a significant position in eBay (EBAY) during the Third Quarter. While eBay’s challenges were well‐mapped – including multiple years of minimal value growth, a weak execution track record, and high employee turnover – we sensed it had arrived at a critical inflection point and gained new focus. A meeting with CEO John Donahoe this summer left us impressed by his process‐driven approach to optimizing the business.


    We were pleased when Mr. Donahoe announced in September that eBay would split into two by spinning off its PayPal unit. Our work on Alibaba (BABA) since 2011 had persuaded us of the power of the marketplace model in e‐commerce and our work on AliPay convinced us that PayPal was an incredibly well‐positioned global brand with the potential to become a leading player in mobile payments. Following the spinoff, eBay/PayPal will offer two appealing growth, relative value, and capital return profiles for investors.

      


  • Daniel Loeb Comments on Amgen Inc

    Since its founding in 1980, Amgen (AMGN) (“the company”) has been a pioneer in the biotechnology industry, successfully discovering, developing, and marketing therapeutic agents that have meaningfully impacted human health. From 1989 to 2002, Amgen grew five revolutionary biologic drugs into billion dollar blockbuster products in oncology, nephrology, and inflammation. Today, Amgen is a $105 billion market cap company with annual revenues of nearly $20 billion and annual net income e of over $5billion.


    Considering this track record, Amgen’s long‐term underperformance relative to its biotech peers is surprising. The company has a compelling mix of long‐duration, high‐margin mature products like Neulasta and Enbrel, and a number of exciting high growth assets, including recently launched blockbusters like Prolia and Xgeva along with innovative late-stage pipeline assets like evolocumab. Yet, using nearly any valuation metric, the Company trades at a substantial discount to peers. Amgen even trades at a discount to the US pharmaceutical sector, despite superior revenue and earnings growth rates. Amgen’s current discount to fair valuation – and the lack of structural hurdles to closing this gap – make it an attractive investment opportunity. Third Point is now one of the company’s largest shareholders.

      


  • Third Point Q3 2014 Investor Letter

    This is the excerpt from the shareholder letter of Third Point Capital.


    Going forward, we expect that the US will remain the best place to invest, credit opportunities will stay slim, and large cap opportunities with a constructivist angle will become more promising. Although consensus has shifted to lower growth, slower inflation, modest rates, and continued monetary expansion, we think the markets will resume an overall upward trajectory in the US through year‐end.

      


  • Invest In These Hedge Funds At A Discount

    As of the close on 10/13/2014, Greenlight Reinsurance (GLRE), Third Point Reinsurance (TPRE), and Pershing Square Holdings (AEX:PSH) were selling at discounted prices compared to their book values. These three companies are led by 3 of the top investing gurus we follow, David Einhorn, Daniel Loeb, and Bill Ackman.


    Einhorn and Loeb are following the Warren Buffett model of using the float from an insurance company to essentially make investments on what is similar to an investment free loan. When insurance premiums are collected, the capital has to stay with the company in order to pay out the claims. The premiums collected, but not paid out yet, are referred to as float. As long as the underwriting business is profitable, the float mimics an interest free loan. A common metric used is the combined ratio. A ratio of 100 is break-even, and the lower the number, the more profitable the business. The underwriting profit is simply measured as premiums received minus expenses. In some years, claims might be higher due to certain events, so enough liquidity must be retained to pay them out. Most insurance companies invest the float in fixed income to generate extra cash flow and increase profits. The float from Greenlight Re and Third Point Re is managed by the hedge funds Greenlight Capital and Third Point. Einhorn is the manager of Greenlight Capital and Loeb is the manager of Third Point.

      


  • Caxton Associates Bought this Stock

    In this article, let´s consider Anheuser-Busch InBev SA/NV (NYSE:BUD), a $180.02 billion market cap. which has a trailing P/E ratio that indicates that the stock is relatively undervalued (PE 21.9x vs Industry Median 24.8x).


    So in this article, let's take a look at a model which is applicable to stable, mature, dividend-paying firms and try to find the intrinsic value of the stock. Although the model has a number of characteristics that make it useful and appropriate for many applications, it is by no means the be-all and end-all for valuation. The purpose is to force investors to evaluate different assumptions about growth and future prospects.

      


  • Dow Chemical´s Promising Future

    In this article, let's take a look at The Dow Chemical Company (NYSE:DOW), a $65.41 billion market cap company, which is the largest U.S. chemical company and provides chemical, plastic andagricultural products as well as services.


    Portfolio Mix

      


  • Daniel Loeb's New Stocks

    Dan Loeb is CEO of Third Point LLC, founded in 1995, where he oversees all investment activity. Third Point describes its underlying strategy as “event-driven, value-oriented,” and says it “seeks to identify situations where we anticipate a catalyst will unlock value,” on its website.

      


  • Top Hedge Fund Managers Are Buying Ally Financial

    Now that the investment management firms have filed their Form 13Fs with the SEC, we can gain better insight into which securities the investing gurus are buying and selling. The S&P 500 Grid at GuruFocus can be used to find the top buys, sells and net buys based on a number of different categories.


    Using the grid, I found that many of the investing gurus have been initiating positions in Ally Financial (ALLY). There were 10 buyers of the stock in the second quarter and none of the gurus we follow have sold any shares. The buyers include hedge funds titans such as George Soros (Trades, Portfolio), Daniel Loeb (Trades, Portfolio), John Paulson (Trades, Portfolio), Howard Marks (Trades, Portfolio), and Jeremy Grantham (Trades, Portfolio). There is no other stock that has had as many buyers without at least one other manager selling. Daniel Loeb (Trades, Portfolio) of Third Point LLC has the largest position of 45.595 million shares, representing 9.45 percent of the shares outstanding and 13.4 percent of his portfolio. He actually obtained his position in private transactions prior to the IPO that occurred on April 10 of this year.

      


  • Which Is The Better Buy?: Einhorn's Greenlight Re or Loeb's Third Point Re

    Within the past week both Greenlight Re (GLRE) and Third Point Re (TPRE) released their second quarter earnings for 2014. The reinsurance companies both have investing gurus we follow running the investment portfolios. David Einhorn handles the portfolio for Greenlight Re, and Daniel Loeb is in charge of Third Point Re’s portfolio. Einhorn and Loeb started their long/short hedge funds in the mid-1990s and have had annual gains of about 20 percent each since inception.


    The two reinsurance companies are ways to gain access to the hedge funds while potentially receiving even higher returns if the insurance underwriting businesses are profitable. The metric that insurance companies use to measure underwriting profits is the combined ratio. A combined ratio of 100 indicates break even and the lower the number, the more profitable the underwriting business is. Greenlight Re and Thirdpoint Re are both relatively new companies, and it takes time to establish the insurance business so it can provide consistent underwriting profits. Greenlight Re has already reached the point of consistent profits, but Third Point Re is still developing its business and is not yet there.

      


  • Global Market Valuations And Expected Returns - August 6, 2014

    In January 2014, the U.S. stock market benchmark S&P 500 lost 3.36% after the excellent 2013. The enthusiasm went back as the market gained 4.31% over February. In March, it went up only 0.69%. In April, it was about even for the whole month. In May, the market gained 2.10% and in June, the market benchmark S&P 500 went up 1.91%. However, in July, the market went down by 1.51%.


    What is the situation in the other parts of the world? In July, the key indexes in Europe had negative return figures. Germany’s DAX index declined 4.33%. France’s CAC-40 index lost 4.00%. The FTSE 100 index moderately went down by 0.20%. Stock markets performances in Asia were very strong. Japan’s NIKKEI 225 gained 3.03%. Hong Kong’s Hang Seng Index surged 6.75% and China’s SSE Composite index surged 7.48%.

      


  • Third Point Comments on Royal DSM NV

    Over the past three years, Royal DSM NV (“DSM”) has transformed itself into a leading global life sciences company focused on health and nutrition with ~$12 billion of sales and ~$1.7 billion of EBITDA. DSM’s portfolio of businesses also includes legacy activities in materials sciences. While the Materials segments account for ~55% of sales, their profit contribution to the DSM group (~30% of EBITDA) has been greatly surpassed by that of the Nutrition segment (~70% of EBITDA). Earlier this year, DSM shares sold-off following: i) a profit warning in the Nutrition segment, and ii) growing skepticism about DSM’s ability to execute on its plan to divest its commodity caprolactam business. The weakness in DSM’s share price served as an opportunity to build our position. We believe that the profit warning in Nutrition was driven by cyclical factors and abnormally adverse weather rather than any structural changes in the underlying fundamentals. We are also optimistic that management can successfully separate its commodity caprolactam exposure through either a sale or joint venture. Finally, near-term trends are positive in both of DSM’s businesses, with Nutrition starting to show signs of reverting to a more normalized growth rate and Performance Materials starting to inflect from depressed levels given its exposure to rebounding European automotive and construction markets.


    DSM group currently trades at 7.5x forward EV/EBITDA. Based on our analysis, we believe that both the Nutrition and Performance Materials segments should command higher multiples than DSM’s current group multiple. The low group valuation is driven by the continued presence of the Performance Materials and Polymer Intermediates segments. These businesses have de minimis end-market overlap or synergies with Nutrition. Furthermore, the non-nutrition businesses are structurally more volatile and have lower returns, making the combined entity cumbersome for investors to analyze and appropriately value.

      


  • Daniel Loeb’s Third Point Second Quarter 2014 Investor Letter

    Review and Outlook


    Markets moved higher in the first half of 2014, despite an early sell-off in heavily-owned hedge fund names and popular technology stocks. While investors perceived the market as volatile, the +7% return for the first half largely exceeded expectations.

      


  • Einhorn Is Transforming BioFuel Energy Into A Profitable Real Estate Company

    Two of the gurus that I follow at GuruFocus are David Einhorn and Daniel Loeb. They are both considered to be activist investors and their hedge funds have experienced extraordinary results. Loeb started Third Point Capital in 1995 and Einhorn started Greenlight Capital in 1996. Third Point Capital has returned 20.4 percent annulized since its inception in 1995, and Greenlight Capital has returned 19.5 percent annualized since May of 1996.


    Together they hold 52.8 percent of BioFuel Energy Corp (BIOF) with Einhorn holding 35.4 percent and Loeb holding 17.4 percent of the shares outstanding (including B Shares) according to the Form S-1 filed with the SEC on 7/16/2014. BioFuel is going through some major changes and will be reinventing itself as a real estate company. With the exceptional track record of the two hedge fund managers, Biofuel Energy is going to be a stock to keep an eye on.

      


  • Top Insider Sells Highlight: Cytec Industries Inc.

    Vice President and CFO of Cytec Industries Inc. (NYSE:CYT) David Drillock sold 49,038 shares on July 21 at an average price of $107.06. The total transaction amount was $5,250,008.


    Cytec Industries was incorporated as an independent public company in December 1993. Cytec Industries Inc has a market cap of $3.85 billion; its shares were traded at around $107.42 with a P/E ratio of 20.70 and P/S ratio of 2.10. The dividend yield of Cytec Industries stocks is 0.50%. Cytec Industries had an annual average earnings growth of 46.60% over the past 5 years.

      


  • Top Insider Sells Highlight: Google Inc.

    CEO and 10% Owner of Google Inc (NASDAQ:GOOG) Lawrence Page sold 33,332 shares on July 14 at an average price of $586.48. The total transaction amount is $19,548,551.


    Google was incorporated in California in Sept. 1998 and reincorporated in Delaware in Aug. 2003. Google Inc has a market cap of $394.43 billion; its shares were traded at around $584.78 with a P/E ratio of 30.80 and P/S ratio of 6.30. Google Inc had an annual average earnings growth of 33.30% over the past 10 years. GuruFocus rated Google Inc the business predictability rank of 3-star.

      


  • Gain Access to Daniel Loeb’s Hedge Fund Through Third Point Re

    Through my research of Greenlight Re (GLRE), I discovered Third Point Reinsurance (TPRE). Third Point Re was listed as the most similar, publicly traded competitor to Greenlight Re. The company is a way to gain access to Daniel Loeb’s hedge fund without needing the typical $1 million to invest in such a fund. Loeb has been one of the best performing gurus that we follow at GuruFocus. Third Point’s funds have blown away the S&P 500 over the years. The Master Fund has provided an annual return of 20.4 percent since inception in 1995 compared to the S&P 500’s annual return of 9.7 percent.


      


  • What Guru Investors Did with Bill Ackman's Herbalife in Q1

    When an investor as prominent as Bill Ackman (Trades, Portfolio) makes a short case of a public company, many other investors will either agree with him, or view it as an opportunity to take a long position on the ensuing dip. But in the case of weight-loss and nutrition company Herbalife (NYSE:HLF), its stock has had a tortuous ride since Ackman announced his short in 2012, as no ultimate determination about his thesis has been made. That didn’t stop fund managers from taking sides again in the first quarter.

    Ackman’s initial announcement of his $1 billion short against Herbalife in April 2012 immediately sunk the company’s stock by more than a third. In December 2012, it plunged again by about 38%. His victory was short-lived, however, when in the next year Herbalife’s soared to all-time highs.  


  • Top 5 Hedge Fund Net Buys

    The recent top net buys of the hedge fund gurus were American Airlines (NASDAQ:AAL), Actavis (NYSE:ACT), Allegion (NYSE:ALLE), Gilead Sciences (NASDAQ:GILD), and Verizon (NYSE:VZ). I found the net buys by using the S&P 500 Grid at GuruFocus. I adjusted the setting to include only hedge fund gurus and examined the results for both S&P 500 companies and non-S&P 500 companies.


    American Airlines Group (AAL) 14 (16 buys, 2 sells)

      


  • Can Loeb Reinvigorate Sotheby’s?

    Now that Third Point LLC’s founder and CEO, Daniel Loeb, and the board of Sotheby’s (BID) have come to an agreement, is now the time to buy the stock? There is currently an opportunity to buy it at a lower price than Loeb. He currently has 6.35 million shares valued at valued a little under $260 million. His average purchase price is $43.91 with his purchases starting in February of 2013. The stock is now trading for about 7 percent less at $40.76.


    1399668491021.png

      


  • Daniel Loeb Comments on SoftBank Corp

    SoftBank Corp. (TSE:9984)("SoftBank") Update Following its strong rally at year‐end, SoftBank shares pulled back 15% during Q1 2014. We believe this pullback was due to technical trading and that SoftBank's fundamentals are stronger than when we initiated the position during the fourth quarter of 2013. SoftBank has continued to demonstrate significant value growth in key drivers across each of its underlying businesses. The Japanese wireless segment successfully navigated the temporary impact of NTT's iPhone offering and seasonal promotional activity in March 2014, while consensus valuations for Alibaba Group have grown from $120 billion to $171 billion year‐to‐date. These trends play into the four‐pronged equity value expansion story for SoftBank shares:


    1) SoftBank Mobile value expansion of ¥230 per share annually (EBITDA growth, constant multiple)

      


  • Daniel Loeb Comments on IHI Corporation

    Equity Position: IHI Corporation ("IHI")(TSE:7013)


    IHI is a mid‐cap Japanese conglomerate exposed to three big themes: commercial aerospace, automotive fuel efficiency, and Abenomics‐led real estate reflation in Tokyo.

      


  • Third Point (Dan Loeb) Q1 2014 Letter to Investors



  • Global Market Valuations and Expected Returns – April 4, 2014

    In January 2014, the U.S. stock market benchmark S&P 500 lost 3.36% after an excellent 2013. The enthusiasm went back as the market gained 4.31% over February. In March, it went up only 0.69%. The market benchmark S&P 500 closed at 1890.90 on April 2, 2014, which is the new record high. What is the situation in the other parts of the world? In March, the key indexes in Europe returned negative. Germany’s DAX index declined 1.40%. France’s CAC-40 index lost 0.38%. The FTSE 100 index was down 3.10%. Stock market performances in Asia were weak too. Japan’s NIKKEI 225 moderately decreased 0.09%. Hong Kong’s Hang Seng Index was down 3.00% and China’s SSE Composite index was down 1.12% due to the weaker-than-expected Chinese economic data.


    Seth Klarman has returned $4 billion to clients at 2013 year-end due to lack of ideas and has 40% of the portfolio in cash. In his 2013 letter to investors, he mentioned the Continuing Problems in Europe, “Europe isn’t fixed either, but you wouldn’t be able to tell that from investor sentiment. One sell-side analyst recently declared that ‘the recovery is here,’ a sharp reversal from his view in July 2012 that Greece had a 90% chance of leaving the Euro by the end of 2013. Greek government bond prices have nearly quintupled in price from the mid-2012 lows. Yet, despite six years of painful structural adjustments, Greece’s government debt-to-GDP ratio currently stands at 157%, up from 105% in 2008. Germany’s own government debt-to-GDP ratio stands at 81%, up from 65% in 2008. That doesn’t look fixed to us. The EU credit rating was recently reduced by S&P. European unemployment remains stubbornly above 12%. Not fixed.

      


  • Big Solutions to Improve Dow's Balance Sheet

    The Dow Chemical Company (NYSE:DOW) is the largest U.S. chemical maker by sales. It is engaged in manufacturing and supplying products used primarily as raw materials in the manufacture of customer products and services. The company serves the following industries: appliance; automotive; agricultural; building and construction; chemical processing; electronics; furniture; housewares; oil and gas; packaging; paints, coatings and adhesives; personal care; pharmaceutical; processed foods; pulp and paper; textile and carpet; utilities; and water treatment.


    In this article, let's take a look at this company and try to explain to investors the reasons this is an apparently appealing investment.

      


  • Diversification, Hedging and Joint-Ventures Are Cabot´s Long-Term Drivers

    Cabot Oil & Gas Corp. (NYSE:COG) is an oil and gas company engaged in the development, exploitation, exploration, production and marketing of natural gas, crude oil and, to a lesser extent, natural gas liquids. The company also transports, stores, gathers and purchases natural gas for resale.


    In this article, let's take a look at this company and try to explain to investors the reasons this is an apparently appealing investment.

      


  • Absolute and Relative Valuation Models Indicate the Same: Abbot Is a Buy

    Abbott Laboratories (NYSE:ABT) is engaged in the discovery, development, manufacture and sale of health care products. Market-based metrics indicate that the stock is relatively undervalued. So now let's take a look at the intrinsic value of this company and try to explain to investors the reasons why it is a good buy or not. With a dividend-payment history that affirms its commitment to maximize shareholder wealth, the company raised its quarterly dividend by 57% to $0.22 per share from $0.14. Its dividend yield is 1.67%, ahead of the industry yield of 1.35%. This makes it interesting to analyze the Discount Dividend Model.


    In this article, we present a model that is by no means the be-all and end-all for valuation. The purpose is to force investors to evaluate different assumptions about growth and future prospects.

      


  • Is Liberty Global Speeding Up Too Quickly?

    Liberty Global Plc (NASDAQ:LBTYA)’s John Malone has a track record for purchasing small and medium-sized companies, with the goal of expanding the media and communications empire. The most recent example of this strategy was seen at the beginning of the month, when the company acquired the remaining 20% of Chile’s largest cable operator VTR for 10.1 million shares ($422 million). Furthermore, to guarantee the firm’s proper management and elevate the customer experience, VTR has entered Telecom Italy’s Global Partnership Program, which should help improve operational efficiency. However, while there is no doubt about Liberty’s growth prospects, many investment gurus like Eric Mindich (Trades, Portfolio) and Daniel Loeb (Trades, Portfolio) have been reducing or selling out their shares in the company, due to lax returns on investment.


    As Scale Grows, So Does Debt

      


  • Sotheby's Response to Third Point Litigation

    NEW YORK, March 25, 2014 (GLOBE NEWSWIRE) -- Sotheby's (NYSE:BID) issued the following in response to reports that Third Point has filed litigation against the Company.


    Late last year, Sotheby's adopted a one-year shareholder rights plan, which expires in October 2014 and cannot be extended beyond October 2014 without shareholder approval. It is similar to those adopted by numerous publicly traded companies facing similar situations. Sotheby's shareholder rights plan was adopted in response to rapid accumulations of significant portions of the Company's outstanding common stock, including through derivatives.

      


  • Abbott Capturing Incremental Market Share

    Abbott Laboratories (NYSE:ABT) is engaged in the discovery, development, manufacture, and sale of health care products. The company’s reportable segments include: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, and Vascular Products. Non-reportable segments include the Diabetes Care and Medical Optics segments.


    Let's take a look at this company and try to explain to investors the reasons this is an apparently appealing investment opportunity.

      


  • Activist Billionaire Daniel Loeb in a Battle for Control of Sotheby’s

    Daniel Seth Loeb is founder of Third Point LLC, a New York-based hedge fund. On Feb. 27, he added Sotheby's (NYSE:BID) at an average price of $50.51 and on March 11, he added the stock again at an average price of $47.27. He currently holds 6.65 million shares of the stock with a current value of $293 million in his portfolio and his stake in Sotheby's is about 9.6%. So let's take a look at this company and try to explain to investors the reasons why he is betting on it.


      


  • Sotheby's Open Letter to Shareholders Regarding Third Point’s Board Nominees

    SOTHEBY’S SENDS OPEN LETTER TO SHAREHOLDERS


    • Sotheby’s Has the Right Plan and the Right Team to Continue Building Sustainable Value for Shareholders and Clients
    •   


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)